SCHEDULE 13D/A

REPARE THERAPEUTICS INC

Common Shares · CUSIP: 760273102

Event date: 2025-01-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• MPM BioVentures 2014, L.P.Reported CIK 0001609492

  Shares: 1,018,345.00 · Class: 2.4%

• MPM BioVentures 2014 (B), L.P.Reported CIK 0001609493

  Shares: 67,921.00 · Class: 0.2%

• MPM Asset Management Investors BV2014 LLCReported CIK 0001609495

  Shares: 35,052.00 · Class: 0.1%

• UBS Oncology Impact Fund L.P.Reported CIK 0001691428

  Shares: 819,924.00 · Class: 1.9%

• MPM BioVentures 2014 GP LLCReported CIK 0001765091

  Shares: 1,086,266.00 · Class: 2.6%

• MPM BioVentures 2014 LLCReported CIK 0001765021

  Shares: 1,121,318.00 · Class: 2.6%

• Oncology Impact Fund (Cayman) Management L.P.Reported CIK 0001721036

  Shares: 819,924.00 · Class: 1.9%

• MPM BioImpact LLCReported CIK 0001687078

  Shares: 819,924.00 · Class: 1.9%

• ANSBERT GADICKEReported CIK 0001134655

  Shares: 1,941,242.00 · Class: 4.6%

• LUKE EVNINReported CIK 0001134657

  Shares: 1,121,318.00 · Class: 2.6%

• Todd FoleyReported CIK 0001473930

  Shares: 1,121,318.00 · Class: 2.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.